SCHEMBL16760130

SCHEMBL16760130

CCc1[c][nH]c2ccc(Cl)cc12

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 7/20 0.43
GPR84 Q9NQS5 1/20 0.40
HTR6 P50406 3/20 0.39
LMNA P02545 1/20 0.39
HTR2A P28223 4/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16760066 0.80 HSD17B10 (0.42) LMNAHTR2AGAAHPGD
SCHEMBL701885 0.76 LMNA (0.46) SIRT1GPR84HTR6LMNACYP1A2
SCHEMBL11232989 0.75 GPR84 (0.41) SIRT1GPR84LMNAHTR2ACYP1A2
SCHEMBL640081 0.73 KIF11 (0.39) GPR84CYP1A2HPGD
SCHEMBL7484865 0.72 GPR84 (0.36) GPR84HTR2ATRPM8
SCHEMBL208039 0.72 GPR84 (0.39) SIRT1GPR84LMNAHTR2ACYP1A2
SCHEMBL207498 0.72 GPR84 (0.39) SIRT1GPR84LMNAHTR2ACYP1A2
SCHEMBL210595 0.68 LMNA (0.42) SIRT1GPR84LMNACYP1A2GAA
SCHEMBL15283206 0.67 MEN1 (0.47) LMNAHPGD
SCHEMBL207953 0.66 GFER (0.43) SIRT1LMNACYP1A2GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074385-A1 PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF PSYCHIATRIC AND NEUROLOGICAL CONDITIONS Takeda Pharmaceutical Company Limited (JP) 2016-10-05 EP disclosed
WO-2015079224-A1 PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF PSYCHIATRIC AND NEUROLOGICAL CONDITIONS TAKEDA CAMBRIDGE LIMITED (GB) 2015-06-04 WO disclosed